- Q2 2023 sees surge in cybersecurity-related roles amidst rising digital engagement and data breaches.
- Pharmaceutical companies are prioritising emerging technologies and stringent compliance measures.
- The focus is to minimize enterprise risks and comprehend privacy-related risks linked to new technologies.